Global Sperm Analytical Devices Market 2017-2021

  • ID: 4115435
  • Report
  • Region: Global
  • 78 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • FertiPro
  • Hamilton Thorne
  • MICROPTIC
  • MMCSoft
  • Origio
  • Selinion Medical
  • MORE
About Sperm Analytical Devices

The market will grow moderately at the rate of 7.83% during the forecast period primarily due to the growing prevalence of infertility cases globally among men. In most cases, changes in lifestyle, eating habits, lack of physical exercise, and pollution accompanied by medical disorders like diabetes, leading to stress and obesity, are the major causes of infertility. There are several factors that cause male infertility leading to abnormal sperm production or function. As per some experts, an increase in environmental chemicals can cause a decline in sperm count in men. Therefore, with the rising cases of infertility in men, there has been a significant increase in the number of sperm testing and fertility treatments that have driven the market consistently in the recent years.

The analysts forecast the global sperm analytical devices market to grow at a CAGR of 7.83% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global sperm analytical devices market for 2017-2021. The market is expected to grow steadily owing to an increase in infertility tests, such as sperm tests, and an increase in the number of sperm donors.

The market is divided into the following segments based on geography:
- EMEA
- Americas
- APAC

The report, Global Sperm Analytical Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- Medical Electronic Systems
- Origio
- Vitrolife

Other prominent vendors
- MMCSoft.
- FertiPro
- Hamilton Thorne
- Selinion Medical
- MICROPTIC

Market drivers
- Increase in rate of infertility and obesity-related cases
- For a full, detailed list, view the full report

Market challenges
- Lack of strict regulatory oversight and limited reimbursements
- For a full, detailed list, view the full report

Market trends
- Increasing number of single-parent families
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • FertiPro
  • Hamilton Thorne
  • MICROPTIC
  • MMCSoft
  • Origio
  • Selinion Medical
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by application

Market overview

Fertility clinics in sperm analytical devices market

Hospitals in sperm analytical devices market

Others in sperm analytical devices market

PART 07: Geographical segmentation

Market overview

Sperm analytical devices market in EMEA

Sperm analytical devices market in Americas

Sperm analytical devices market in APAC

PART 08: Market drivers

Increase in rate of infertility and obesity-related cases

Rise in income level of consumers

Rise in geriatric population

Growth in technological advances

PART 09: Impact of drivers

PART 10: Market challenges

Lack of strict regulatory oversight and limited reimbursements

High cost of sperm testing

Ineffective distribution networks in developing and under-developed countries

PART 11: Impact of drivers and challenges

PART 12: Market trends

Increasing number of single-parent families

Growing number of egg, sperm, and embryo donors

Increasing acceptance of same-sex marriages

Rising medical tourism initiatives globally

PART 13: Vendor landscape

Competitive scenario

PART 14: Key vendor analysis

Medical Electronic Systems

Origio

Vitrolife

Other prominent vendors

PART 15: Appendix

List of abbreviations

PART 16: About the Author

List of Exhibits
Exhibit 01: China€™s growth potential
Exhibit 02: Global hubs for fertility tourism
Exhibit 03: Infertility treatment key statistics
Exhibit 04: Etiology: Causes of male infertility
Exhibit 05: Timeline of fertility treatment procedures
Exhibit 06: Stages of infertility treatment
Exhibit 07: Global sperm analytical devices market 2016-2021 ($ millions)
Exhibit 08: PESTEL analysis of ART market
Exhibit 09: Five forces analysis
Exhibit 10: Global sperm analytical devices by end-users 2016 and 2021
Exhibit 11: Opportunity analysis of global sperm analytical devices market
Exhibit 12: Fertility clinics in sperm analytical devices market 2016-2021 ($ millions)
Exhibit 13: Number of visitors to fertility clinics in medical tourism hotspots worldwide 2013-2015
Exhibit 14: Hospitals in sperm analytical devices market 2016-2021 ($ millions)
Exhibit 15: Top ten countries with most number of hospitals 2014-2015
Exhibit 16: Others in sperm analytical devices market 2016-21 ($ millions)
Exhibit 17: Global sperm analytical devices market by geography 2016-2021
Exhibit 18: Snapshot: Global sperm analytical devices market by geography
Exhibit 19: Sperm analytical devices market in EMEA 2016-2021 ($ millions)
Exhibit 20: Sperm analytical devices market in the Americas 2016-2021 ($ millions)
Exhibit 21: US birth rates by women's age group
Exhibit 22: Sperm analytical devices market in APAC 2016-2021 ($ millions)
Exhibit 23: Obesity prevalence in US
Exhibit 24: Global urban population (%)
Exhibit 25: Change in world€™s population by age 2010-2050 (%)
Exhibit 26: Impact of drivers
Exhibit 27: Impact of drivers and challenges
Exhibit 28: Single-parent families by gender in US 2015
Exhibit 29: Same-sex married couples in US
Exhibit 30: Competitive parameters
Exhibit 31: Strategic success factors of consideration for companies
Exhibit 32: Product offerings
Exhibit 33: Medical Electronic Systems: Profile
Exhibit 34: Medical Electronic Systems: Strength analysis
Exhibit 35: Medical Electronic Systems: Strategy assessment
Exhibit 36: Medical Electronic Systems: Opportunity assessment
Exhibit 37: Product offerings
Exhibit 38: Origio: Profile
Exhibit 39: Origio: Strength analysis
Exhibit 40: Origio: Strategy assessment
Exhibit 41: Origio: Opportunity assessment
Exhibit 42: Product offerings
Exhibit 43: Vitrolife: Profile
Exhibit 44: Vitrolife: Strength analysis
Exhibit 45: Vitrolife: Strategy assessment
Exhibit 46: Vitrolife: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • FertiPro
  • Hamilton Thorne
  • MICROPTIC
  • MMCSoft
  • Origio
  • Selinion Medical
  • MORE
New Report Released: – Global Sperm Analytical Devices Market 2017-2021

The author of the report recognizes the following companies as the key players in the Global Sperm Analytical Devices Market: Medical Electronic Systems, Origio, and Vitrolife.

Other Prominent Vendors in the market are: MMCSoft, FertiPro, Hamilton Thorne, Selinion Medical, and MICROPTIC.

Commenting on the report, an analyst from the research team said: “One trend in the market is the increasing number of single-parent families. In the last few years, the number of single women using fertility clinics had doubled since the start of the decade. The large majority of single parents are either divorced, separated, widowed or unmarried. This trend of single-parent families is gaining traction due to social acceptance. One major reason is that there has been a notable increase in divorces in developed countries, such as the US, resulting in an increased number of single-parent families. With the growing idea of a single parent, fertility clinics have started to help many single individuals, both women and men, to achieve parenthood. For example, a single woman seeking for parental options will get services such as sperm donation (with or without fertility medications), IVF with donor sperm, and IVF with donor sperm and donor eggs. All these services revolve around the use of sperm that are donated by healthy sperm donors who are scrutinized through several sperm analysis tests before donation of sperm. This is likely to create an increase in demand for sperm analytical devices.”

According to the report, one driver in the market is the Increase in rate of infertility and obesity-related cases. Globally, there has been a notable increase in the rate of infertility due to several reasons, including changing lifestyle that plays a considerable role in determining the body's physiology. Consumption of alcohol and drugs has an adverse effect on health and leads to infertility. Likewise, the modern work culture involves minimal physical activity and more desk work and mental stress. There is a rise in trend of men not taking time off work to have a child due to the enormous expense of raising a child. An increasing number of couples are choosing to wait longer to have children, which is likely to cause lesser chances of conceiving because of reduced fertility rates, thereby necessitating regular sperm tests to investigate the quality and quantity of sperm.

Further, the report states that one challenge in the market is the lack of strict regulatory oversight and limited reimbursements
Sperm analysis has become an essential tool for the evaluation of an infertile couple. Sperm analysis and infertility treatment are considered lifestyle procedures rather than serious medicine. Health insurance policies commonly, but not always, pay for services related to testing for infertility. For instance, in the US, which does not have any infertility coverage mandate, most insurance policies do not help with infertility (including for sperm testing) service payment. There is no federal law regulating reimbursement of medical bills in the US. Reimbursement policies either do not cover infertility services and or only cover them partially, limiting the use of these services. The Affordable Care Act does not provide coverage for infertility treatments. Sometimes the cost of sperm testing services, such as IVF, are expensive, which discourages people to avail these services with limited insurance coverage. Since the cost of these services is high, individuals often have to rely on insurance and reimbursements, which are generally not covered by most countries. Individuals are sometimes required to go through multiple rounds of sperm testing to test the quality of sperm over a period, thus making it a high-cost procedure. The lack of these financial facilities can turn away potential candidates from opting for these services and hamper the market growth.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Medical Electronic Systems
  • Origio
  • Vitrolife
  • MMCSoft
  • FertiPro
  • Hamilton Thorne
  • Selinion Medical
  • MICROPTIC
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll